Authors:
YUNG GL
CHANNICK RN
FEDULLO PF
AUGER WR
KERR KM
JAMIESON SW
KAPELANSKI DP
MOSER KM
Citation: Gl. Yung et al., SUCCESSFUL PULMONARY THROMBOENDARTERECTOMY IN 2 PATIENTS WITH SICKLE-CELL DISEASE, American journal of respiratory and critical care medicine, 157(5), 1998, pp. 1690-1693
Authors:
PRITCHARD SC
KERR KM
LLORET C
NICHOLSON MX
COCKBURN JS
JEFFREY RR
MCLEOD H
Citation: Sc. Pritchard et al., EVALUATION OF AN ENRICHMENT APPROACH FOR SELECTION OF PROGNOSTIC MARKERS IN NSCLC, British Journal of Cancer, 78, 1998, pp. 78-78
Authors:
MACKINNON M
KERR KM
KING G
KENNEDY MM
COCKBURN JS
JEFFREY RR
Citation: M. Mackinnon et al., P53, C-ERBB-2 AND NM23 EXPRESSION HAVE NO PROGNOSTIC-SIGNIFICANCE IN PRIMARY PULMONARY ADENOCARCINOMA, European journal of cardio-thoracic surgery, 11(5), 1997, pp. 838-841
Authors:
DYKHUIZEN RS
SMITH CC
KENNEDY MM
MCLAY KA
COCKBURN JS
KERR KM
Citation: Rs. Dykhuizen et al., NECROTIZING SARCOID GRANULOMATOSIS WITH EXTRAPULMONARY INVOLVEMENT, The European respiratory journal, 10(1), 1997, pp. 245-247
Authors:
COOPER CA
CAREY FA
BUBB VJ
LAMB D
KERR KM
WYLLIE AH
Citation: Ca. Cooper et al., THE PATTERN OF K-RAS MUTATION IN PULMONARY ADENOCARCINOMA DEFINES A NEW PATHWAY OF TUMOR-DEVELOPMENT IN THE HUMAN LUNG, Journal of pathology, 181(4), 1997, pp. 401-404
Citation: Ad. Kennedy et al., HBME-1 AND ANTITHROMBOMODULIN IN THE DIFFERENTIAL-DIAGNOSIS OF MALIGNANT MESOTHELIOMA OF PLEURA, Journal of Clinical Pathology, 50(10), 1997, pp. 859-862
Citation: Mm. Kennedy et al., CELL-PROLIFERATION, CELL LOSS AND EXPRESSION OF BCL-2 AND P53 IN HUMAN PULMONARY NEOPLASMS, British Journal of Cancer, 75(4), 1997, pp. 545-547
Citation: Km. Kerr et L. Hedstrom, THE ROLES OF CONSERVED CARBOXYLATE RESIDUES IN IMP DEHYDROGENASE AND IDENTIFICATION OF A TRANSITION-STATE ANALOG, Biochemistry, 36(43), 1997, pp. 13365-13373
Citation: Km. Kerr et L. Hedstrom, EDC INACTIVATION IMPLICATES CARBOXYLATE RESIDUES IN THE MECHANISM OF ESCHERICHIA-COLI IMPDH, The FASEB journal, 10(6), 1996, pp. 17-17
Citation: Mm. Kennedy et al., EXPRESSION OF BCL-2 AND P53 IN MERKEL CELL-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY, The American journal of dermatopathology, 18(3), 1996, pp. 273-277
Authors:
CAREY FA
COOPER CA
BUBB VJ
LAMB D
KERR KM
WYLLIE AH
Citation: Fa. Carey et al., THE PATTERN OF K-RAS MUTATION IN PULMONARY ADENOCARCINOMAS DEFINES A NEW PATHWAY OF TUMOR-DEVELOPMENT IN THE HUMAN LUNG, Journal of pathology, 179, 1996, pp. 7-7
Authors:
KERR KM
AUGER WR
FEDULLO PF
CHANNICK RH
YI ES
MOSER KM
Citation: Km. Kerr et al., LARGE VESSEL PULMONARY ARTERITIS MIMICKING CHRONIC THROMBOEMBOLIC DISEASE, American journal of respiratory and critical care medicine, 152(1), 1995, pp. 367-373
Citation: Km. Kerr et al., ATYPICAL ALVEOLAR HYPERPLASIA - RELATIONSHIP WITH PULMONARY ADENOCARCINOMA, P53, AND C-ERBB-2 EXPRESSION, Journal of pathology, 174(4), 1994, pp. 249-256
Citation: Km. Kerr et Nj. Douglas, PATHOLOGICAL ASSESSMENT OF MEDIASTINAL LYMPH-NODES IN LUNG-CANCER - IMPLICATIONS FOR NONINVASIVE MEDIASTINAL STAGING - REPLY, Thorax, 48(5), 1993, pp. 584-584
Citation: Jb. Hewitt et al., MERKEL CELL AND SQUAMOUS-CELL CARCINOMAS ARISING IN ERYTHEMA AB IGNE, British journal of dermatology, 128(5), 1993, pp. 591-592